At the completion of this activity, the participant will be able to:
1.       Identify risk factors for the development of left ventricular (LV) thrombus
2.       Discuss current guideline-recommended therapy for the treatment of LV thrombus
3.       Review recent literature supporting the use of direct oral anticoagulants (DOACs) in LV thrombus
4.       Describe important considerations regarding the use of DOACs in the treatment of LV thrombus

Session date: 
10/22/2021 - 12:00pm to 1:00pm EDT
Location: 
FH Learning Center #1 & Zoom
https://highmarkhealth.zoom.us/j/98341239262
Meeting ID: 983 4123 9262
Passcode: 704409
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.